2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
S

2020 ASCO Update on Recurrent Ovarian Cancer: Who Should Have a Secondary Cytoreduction?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Sarah Temkin
By 2020 ASCO Virtual Direct™ Highlights FEATURING Sarah Temkin
51 views
July 16, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

21:09
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay
GYN
14:29
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Recurrent Ovarian Cancer: Who Should Have a Seco…

Feat. S. Temkin
15:50
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on PARPi in Ovarian Cancer: Is BRCA Related to Ther…

Feat. S. Temkin
08:11
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update: What Is the Long-term Oncological Safety of SNL Bi…

Feat. S. Temkin